Renee Wegrzyn Tapped to Head ARPA-H

As the new agency’s director, the DARPA veteran will spearhead a high-risk, high-reward approach to biomedical research.

Written byAndy Carstens
| 2 min read
woman smiling at camera
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

President Joe Biden will appoint Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health, a new agency intended to accelerate the pace of biomedical research, according to a statement issued by the White House today (September 12). Wegrzyn, who currently works at the biotechnology company Ginkgo Bioworks, is a biologist who was previously a program manager in the Biological Technologies Office of the Defense Advanced Research Projects Agency (DARPA) and has served on several scientific advisory boards for the National Academies of Science, the statement goes on to say.

“I am deeply honored to have the opportunity to shape ARPA-H’s ambitious mission and foster a vision and approach that will improve health outcomes for the American people, including President Biden’s Cancer Moonshot,” says Wegrzyn in a statement issued by Ginkgo Bioworks.

The new agency will support a broad range of programs aimed at preventing, detecting, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens is a freelance science journalist who is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has previously appeared in AudubonSlateThem, and Aidsmap. View his full portfolio at www.andycarstens.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies